Genentech degrader-antibody conjugates targeting BRD4 show anticancer activity March 24, 2022 No Comments
Novel CD56-targeting MMAE-conjugated antibody shows efficacy in models of MCC March 23, 2022 No Comments
RNAGene and PharmAbcine collaborate to develop next-generation mRNA-based antibody therapeutics March 22, 2022 No Comments
NexImmune partners with Zephyr AI to discover novel targets for T-cell-mediated therapies for cancer March 18, 2022 No Comments
WTX-124, a conditionally activated IL-2 prodrug with minimized toxicity in cancer models March 18, 2022 No Comments
RSS